(Q35129772)

6 August 2017

title

Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases (English)

1 reference

6 August 2017

1 reference

2

Marcelo E Bigal

1 reference

6 August 2017

6

Stewart J Tepper

1 reference

6 August 2017

Alan M Rapoport

1

1 reference

6 August 2017

Michel Volcy

series ordinal

3

1 reference

6 August 2017

Fred D Sheftell

series ordinal

4

1 reference

6 August 2017

Michele Feleppa

series ordinal

5

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

43

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

482-489

1 reference

Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Medication misuse headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Prevalence of frequent headache in a population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Tension-type and chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Analgesic rebound headache in clinical practice: data from a physician survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Long-term follow-up of patients treated for chronic headache with analgesic overuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Triptans are all different

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

The nociceptive flexion reflex as a tool for exploring pain control systems in headache and other pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Migraine MLT-down: an unusual presentation of migraine in patients with aspartame-triggered headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

Naratriptan in the prophylaxis of transformed migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03094.X

10.1046/J.1526-4610.2003.03094.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference